...
首页> 外文期刊>Chemical Engineering Research & Design: Transactions of the Institution of Chemical Engineers >Formulation development and statistical optimization of ibuprofen-loaded polymethacrylate microspheres using response surface methodology
【24h】

Formulation development and statistical optimization of ibuprofen-loaded polymethacrylate microspheres using response surface methodology

机译:用响应面法研究布洛芬负载的聚甲基丙烯酸甲酯微球的配方开发和统计优化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The present investigation was aimed at developing a controlled release dosage form of 'ibuprofen-loaded polymethacrylate microspheres' by optimization technique using software based response surface methodology. The microspheres were prepared by emulsion solvent evaporation method in which three process variables were of importantce such as drug:polymer ratio, stirring speed and emulsifier concentration. The desired responses are percentage yield, particle size, entrapment efficiency and in vitro drug release in 12h from the microspheres. Optimization was done by fitting experimental data to the software program (Design-Expert (R) 7 trial version). Product batches were subjected to various characterization tests which are mandatory for the development of dosage form. The optimized batch of formulation showed satisfactory yield (82.00 +/- 1.18%) and drug entrapment efficiency (82.15 +/- 1.35%). Particles were of spherical shape, smooth surface and good flowability, and its average particle size is 133.4 +/- 2.27 mu m. The developed optimized batch of microspheres ensured sustained release (>12 h) of ibuprofen. No chemical interaction was observed between ibuprofen and polymer-Eudragit RSPO as evidenced by Fourier transform-infrared (FTIR) spectroscopy and differential scanning calorimetry (DSC) studies. In conclusion, development of controlled release drug delivery system of ibuprofen was successfully made. (C) 2015 The Institution of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
机译:本研究旨在通过基于技术的基于响应面方法的优化技术,开发“布洛芬负载的聚甲基丙烯酸微球”的控释剂型。通过乳液溶剂蒸发法制备了微球,其中三个工艺变量如药物:聚合物比,搅拌速度和乳化剂浓度是重要的。所需的响应是百分数收率,粒径,包封效率和微球在12小时内的体外药物释放。通过将实验数据拟合到软​​件程序(Design-Expert(R)7试用版)中来进行优化。对产品批次进行各种表征测试,这对于剂型的开发是必需的。优化批次的制剂显示令人满意的收率(82.00 +/- 1.18%)和药物截留效率(82.15 +/- 1.35%)。颗粒为球形,表面光滑,流动性好,平均粒径为133.4 +/-2.27μm。开发的优化的微球批次确保了布洛芬的持续释放(> 12小时)。傅里叶变换红外(FTIR)光谱和差示扫描量热法(DSC)研究证明,布洛芬与聚合物-Eudragit RSPO之间未观察到化学相互作用。综上所述,布洛芬控释给药系统的研制成功。 (C)2015化学工程师学会。由Elsevier B.V.发布。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号